Published on in Vol 7, No 8 (2018): August
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/11003, first published
.
Journals
- Fukumoto C, Sawatani Y, Shiraishi R, Zama M, Shimura M, Hasegawa T, Komiyama Y, Fujita A, Wakui T, Kawamata H. Effectiveness of cetuximab as preemptive postsurgical therapy for oral squamous cell carcinoma patients with major risk: a single‐center retrospective cohort study. Investigational New Drugs 2021;39(3):846 View
- Marques O, Brenet E, Gaultier V, Marchand-Crety C. Radiothérapie postopératoire avec cétuximab pour les carcinomes épidermoïdes de la tête et du cou à haut risque de récidive non éligibles au cisplatine : expérience d’un centre et revue de la littérature. Cancer/Radiothérapie 2023;27(1):17 View
- Tao H, Wei Y, Shen Z, Liu Z. Matched-pair analysis of the impact of low-dose postoperative radiotherapy on prognosis in patients with advanced hypopharyngeal squamous cell carcinoma without positive surgical margins and extracapsular extension. Frontiers in Oncology 2023;13 View